Copyright
©The Author(s) 2016.
World J Gastroenterol. Mar 14, 2016; 22(10): 2900-2905
Published online Mar 14, 2016. doi: 10.3748/wjg.v22.i10.2900
Published online Mar 14, 2016. doi: 10.3748/wjg.v22.i10.2900
Figure 1 Tumor-associated NADH oxidase protein expressions in different human gastric cancer lines.
Aliquots of cell lysates were separated by SDS-PAGE and analyzed for tNOX expression by western blot analysis. β-Actin was used as an internal control to monitor for equal loading. Gastric cancer cell lines including, AGS (gastric adenocarcinoma), TMC-1 (derived from the lymph node of a moderately differentiated stomach adenocarcinoma), MKN45 (from the lymph node of a moderately differentiated stomach adenocarcinoma), SNU-1 (from a poorly differentiated primary carcinoma of the stomach), TMK-1 (from a poorly differentiated adenocarcinoma), and SCM (human gastric carcinoma), were used to study the expression of tNOX protein. SDS-PAGE: Sodium dodecyl sulfate polyacrylamide gel electrophoresis; tNOX: Tumor-associated NADH oxidase.
- Citation: Cheng HL, Lee YH, Yuan TM, Chen SW, Chueh PJ. Update on a tumor-associated NADH oxidase in gastric cancer cell growth. World J Gastroenterol 2016; 22(10): 2900-2905
- URL: https://www.wjgnet.com/1007-9327/full/v22/i10/2900.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i10.2900